These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 22790124)

  • 1. Non-alcoholic fatty liver disease is an independent predictor for macroangiopathy in Japanese type 2 diabetic patients: a cross-sectional study.
    Takeuchi Y; Ito H; Komatsu Y; Oshikiri K; Antoku S; Abe M; Mifune M; Togane M
    Intern Med; 2012; 51(13):1667-75. PubMed ID: 22790124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic fatty liver disease is associated with low HDL cholesterol and coronary angioplasty in patients with type 2 diabetes.
    Trojak A; Waluś-Miarka M; Woźniakiewicz E; Małecki MT; Idzior-Waluś B
    Med Sci Monit; 2013 Dec; 19():1167-72. PubMed ID: 24336007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes.
    Agarwal AK; Jain V; Singla S; Baruah BP; Arya V; Yadav R; Singh VP
    J Assoc Physicians India; 2011 Jun; 59():351-4. PubMed ID: 21751587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes.
    Lv WS; Sun RX; Gao YY; Wen JP; Pan RF; Li L; Wang J; Xian YX; Cao CX; Zheng M
    World J Gastroenterol; 2013 May; 19(20):3134-42. PubMed ID: 23716995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Serum Adiponectin with Intima Media Thickness of Dorsalis Pedis Artery and Macroangiopathy in Type 2 Diabetes.
    Chen T; Tu M; Huang L; Zheng Y
    J Diabetes Res; 2020; 2020():4739271. PubMed ID: 31998806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of and predictive factors for nonalcoholic fatty liver disease in Sudanese individuals with type 2 diabetes: Is metabolic syndrome the culprit?
    Almobarak AO; Barakat S; Suliman EA; Elmadhoun WM; Mohamed NA; Abobaker IO; Noor SK; Bushara SO; Ahmed MH
    Arab J Gastroenterol; 2015 Jun; 16(2):54-8. PubMed ID: 26174761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis].
    Choi SY; Kim D; Kang JH; Park MJ; Kim YS; Lim SH; Kim CH; Lee HS
    Korean J Hepatol; 2008 Mar; 14(1):77-88. PubMed ID: 18367860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults.
    Jimba S; Nakagami T; Takahashi M; Wakamatsu T; Hirota Y; Iwamoto Y; Wasada T
    Diabet Med; 2005 Sep; 22(9):1141-5. PubMed ID: 16108839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors.
    Koller T; Kollerova J; Hlavaty T; Huorka M; Payer J
    Scand J Gastroenterol; 2012 Feb; 47(2):197-203. PubMed ID: 22182015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case-control study on the relationship between HDL2b and non-alcoholic fatty liver disease in Chinese type 2 diabetic patients.
    Ma YH; Zhao L; Xian XD; Yang D; Huang W; Wang YH; Mueller O; Chang E; Konigshofer Y; Van-Cleve M; Liu G; Yang JK
    Clin Chem Lab Med; 2009; 47(9):1067-72. PubMed ID: 19728847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of coronary heart disease in type 2 diabetic patients with non-alcoholic fatty liver disease.
    Lu H; Zeng L; Liang B; Shu X; Xie D
    Arch Med Res; 2009 Oct; 40(7):571-5. PubMed ID: 20082871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non-alcoholic fatty liver disease.
    Targher G; Bertolini L; Padovani R; Poli F; Scala L; Tessari R; Zenari L; Falezza G
    Diabet Med; 2006 Apr; 23(4):403-9. PubMed ID: 16620269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians.
    Thakur ML; Sharma S; Kumar A; Bhatt SP; Luthra K; Guleria R; Pandey RM; Vikram NK
    Atherosclerosis; 2012 Aug; 223(2):507-11. PubMed ID: 22748277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic fatty liver disease is associated with late but not early atherosclerotic lesions in Chinese inpatients with type 2 diabetes.
    Guo K; Zhang L; Lu J; Yu H; Wu M; Bao Y; Chen H; Jia W
    J Diabetes Complications; 2017 Jan; 31(1):80-85. PubMed ID: 27742552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic fatty liver disease is associated with aortic valve sclerosis in patients with type 2 diabetes mellitus.
    Bonapace S; Valbusa F; Bertolini L; Pichiri I; Mantovani A; Rossi A; Zenari L; Barbieri E; Targher G
    PLoS One; 2014; 9(2):e88371. PubMed ID: 24505484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of fatty liver on the size and composition of high-density lipoprotein cholesterol subpopulations in adolescents with type 2 diabetes mellitus.
    Orozco Morales JA; Medina Urrutia AX; Torres Tamayo M; Jorge Galarza E; Reyes Barrera J; Díes Suarez P; Juárez Rojas JG; Medina-Bravo P
    Pediatr Diabetes; 2020 Nov; 21(7):1140-1149. PubMed ID: 32812688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients.
    Targher G; Bertolini L; Rodella S; Zoppini G; Lippi G; Day C; Muggeo M
    Diabetologia; 2008 Mar; 51(3):444-50. PubMed ID: 18058083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation analysis of epicardial adipose tissue thickness, C-reactive protein, interleukin-6, visfatin, juxtaposed with another zinc finger protein 1, and type 2 diabetic macroangiopathy.
    Gong YY; Peng HY
    Lipids Health Dis; 2021 Mar; 20(1):25. PubMed ID: 33722242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of serum concentrations of soluble adhesion molecules in diabetic microangiopathy and macroangiopathy.
    Matsumoto K; Sera Y; Ueki Y; Inukai G; Niiro E; Miyake S
    Diabet Med; 2002 Oct; 19(10):822-6. PubMed ID: 12358868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study.
    Weinstein G; Zelber-Sagi S; Preis SR; Beiser AS; DeCarli C; Speliotes EK; Satizabal CL; Vasan RS; Seshadri S
    JAMA Neurol; 2018 Jan; 75(1):97-104. PubMed ID: 29159396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.